## Note
nid: 1544457619643
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step2_v11::!Shelf::FM, #AK_Step2_v11::!Shelf::ObGyn, #AK_Step2_v11::!Shelf::Surgery, #AK_Step2_v11::#OME_banner::Clinical::20_Primer:_Methods_for_Success, #AK_Step2_v11::#Resources_by_rotation::FM::casefiles::osteoporosis, #AK_Step2_v11::#Resources_by_rotation::ObGyn::uw::zanki::female_repro_breast, #AK_Step2_v11::#Resources_by_rotation::Surgery::devirgilio_dorian::breast, #AK_Step2_v11::#Subjects::Orthopedics_&_Rheumatology::02_Pathology::01_Bone::Osteoporosis::Management, #AK_Step2_v11::Original_decks::Dorian::fam::casefiles::osteoporosis, #AK_Step2_v11::Original_decks::Dorian::surg::devirgilio::breast, #AK_Step2_v11::Original_decks::Zanki_Step_2::ObGyn::Female_Repro_&_Breast
markdown: false

### Text
Which <i>selective estrogen receptor modulator</i> (SERM) is
preferred for treatment of <b>postmenopausal osteoporosis</b>?
<div>
  {{c1::Raloxifene}}
</div>

### Extra
<div>
  <div style="font-style: italic;"></div>
</div>
<div>
  <i>Antagonist of estrogen in <u>both</u> breast and endometrium
  therefore no associated cancer risk (vs. tamoxifen, agonist at
  uterus)</i>
</div><img src="paste-327246443184607.jpg"><i><img src=
"SERM_1358629116483.png"></i><i><img src=
"paste-11122178590244865.jpg"></i>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org/spa/surgery?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_3.png"></a>
</div>

### Additional Resources


### One by one

